Integra LifeSciences Cor... (IART)
15.83
0.08 (0.51%)
At close: Apr 17, 2025, 3:59 PM
Integra LifeSciences Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Codman Specialty Surgical Revenue | 270.78M | 301.76M | 256.43M | 268.2M | 271.03M | 248.14M | 264.6M | 249.8M | 257.86M | 247.31M | 270.66M | 256.5M | 256.84M | 241.24M | 254.29M | 239.32M | 169.78M | 231.44M | 259.4M | 252.98M | 249.26M | 249.28M | 239.03M | 239.5M | 236.12M |
| Codman Specialty Surgical Revenue Growth | -10.27% | +17.68% | -4.39% | -1.04% | +9.23% | -6.22% | +5.93% | -3.13% | +4.27% | -8.63% | +5.52% | -0.13% | +6.46% | -5.13% | +6.25% | +40.96% | -26.64% | -10.78% | +2.53% | +1.49% | -0.01% | +4.28% | -0.20% | +1.44% | n/a |
| Tissue Technologies Revenue | 110.05M | 116.41M | 112.44M | 114.22M | 110.24M | 132.71M | 133.43M | 135.4M | 139.95M | 129.33M | 134.87M | 130.36M | 133.16M | 118.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Tissue Technologies Revenue Growth | -5.46% | +3.54% | -1.56% | +3.61% | -16.93% | -0.54% | -1.46% | -3.26% | +8.21% | -4.11% | +3.45% | -2.10% | +12.06% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 176.48M | 182.03M | 157.17M | 157.39M | 144.25M | 150.15M | 120.59M | 103.06M | 105.7M | 93.98M | 90.92M | 44.45M |
| Asia Pacific Revenue Growth | -3.05% | +15.82% | -0.14% | +9.11% | -3.93% | +24.51% | +17.01% | -2.50% | +12.47% | +3.36% | +104.57% | n/a |
| Europe Revenue | 170.9M | 191.33M | 172.69M | 197.47M | 201.35M | 143.83M | 105.88M | 98.85M | 108.57M | 99.54M | 97.12M | 94.77M |
| Europe Revenue Growth | -10.67% | +10.79% | -12.55% | -1.93% | +40.00% | +35.84% | +7.11% | -8.95% | +9.07% | +2.49% | +2.48% | n/a |
| Rest Of World Revenue | 83.48M | 79.56M | 70.03M | 85.32M | 80.95M | 894.26M | 765.61M | 680.82M | 714.04M | 642.69M | 642.83M | n/a |
| Rest Of World Revenue Growth | +4.92% | +13.61% | -17.92% | +5.40% | -90.95% | +16.80% | +12.45% | -4.65% | +11.10% | -0.02% | n/a | n/a |
| United States Revenue | 1.13B | 1.09B | 971.98M | 1.08B | 1.05B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +3.42% | +12.09% | -9.78% | +3.01% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 177.19M | 172.18M | 165.8M | 147.44M | 161.95M | 164.91M | 166.66M | 151.92M | 143.82M | 160.65M | 159.93M | 162.25M | 156.01M | 162.55M | 156.63M | 162.39M | 150.08M | 116.11M | 165.95M | 174.25M | 173.1M | 165.38M | 174.87M | 177.23M | 173.35M | 176.6M | 163.57M | 190.64M | 145.94M | 145.01M | 142.5M | 112.12M | 112.32M | 119.22M | 111.96M | 109.75M | 113.42M | 126.59M | 114.06M |
| Selling, General, and Administrative Revenue Growth | +2.91% | +3.85% | +12.45% | -8.96% | -1.79% | -1.05% | +9.70% | +5.63% | -10.48% | +0.45% | -1.43% | +4.00% | -4.02% | +3.78% | -3.55% | +8.21% | +29.26% | -30.04% | -4.76% | +0.67% | +4.67% | -5.43% | -1.33% | +2.23% | -1.84% | +7.97% | -14.20% | +30.62% | +0.64% | +1.77% | +27.09% | -0.18% | -5.79% | +6.49% | +2.01% | -3.24% | -10.40% | +10.98% | n/a |
| Research and Development Revenue | 27.43M | 25.03M | 26.96M | 24.31M | 26.6M | 26.59M | 26.72M | 26.78M | 24.74M | 25.59M | 24.09M | 24.73M | 25.83M | 20.12M | 22.37M | 22.18M | 19.46M | 14.93M | 20.82M | 24.64M | 19M | 17.63M | 18.32M | 20.3M | 20.31M | 19.11M | 18.32M | 17.18M | 15.03M | 15.75M | 15.49M | 13.9M | 15.12M | 14.68M | 14.45M | 13.87M | 13.94M | 13.89M | 12.56M |
| Research and Development Revenue Growth | +9.59% | -7.16% | +10.92% | -8.59% | +0.03% | -0.51% | -0.22% | +8.28% | -3.33% | +6.24% | -2.59% | -4.28% | +28.38% | -10.07% | +0.88% | +13.97% | +30.38% | -28.30% | -15.53% | +29.68% | +7.77% | -3.76% | -9.74% | -0.05% | +6.29% | +4.27% | +6.66% | +14.27% | -4.53% | +1.63% | +11.46% | -8.09% | +3.03% | +1.58% | +4.22% | -0.52% | +0.34% | +10.63% | n/a |